Rameen Beroukhim

Rameen Beroukhim

Harvard University

H-index: 153

North America-United States

About Rameen Beroukhim

Rameen Beroukhim, With an exceptional h-index of 153 and a recent h-index of 127 (since 2020), a distinguished researcher at Harvard University, specializes in the field of cancer genomics, brain cancers, endometrial cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

The epigenetic evolution of glioma is determined by the IDH1 mutation status and treatment regimen

Author Correction: An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κB

Clinical and genomic predictors of adverse events in newly diagnosed glioblastoma

Aberrant DNA repair reveals a vulnerability in histone H3. 3-mutant brain tumors

Distribution of Copy Number Variants and Impact of Chromosome Arm Call Thresholds for Meningioma

Defining the landscape of cancer vulnerabilities that are engendered by germline genetic variation

Genomic sequence context differs between germline and somatic structural variants allowing for their differentiation in tumor samples without paired normals

DDDR-11. IDENTIFYING NEW VULNERABILITIES TO TARGET PEDIATRIC LOW-GRADE GLIOMA

Rameen Beroukhim Information

University

Harvard University

Position

Dana-Farber Cancer Institute, Harvard Medical School

Citations(all)

165106

Citations(since 2020)

99263

Cited By

100532

hIndex(all)

153

hIndex(since 2020)

127

i10Index(all)

284

i10Index(since 2020)

261

Email

University Profile Page

Harvard University

Rameen Beroukhim Skills & Research Interests

cancer genomics

brain cancers

endometrial cancer

Top articles of Rameen Beroukhim

Title

Journal

Author(s)

Publication Date

The epigenetic evolution of glioma is determined by the IDH1 mutation status and treatment regimen

Cancer research

Tathiane M Malta

Thais S Sabedot

Natalia S Morosini

Indrani Datta

Luciano Garofano

...

2024/3/1

Author Correction: An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κB

Nature medicine

Junxia Min

Alexander Zaslavsky

Giuseppe Fedele

Sara K McLaughlin

Elizabeth E Reczek

...

2024/2/21

Clinical and genomic predictors of adverse events in newly diagnosed glioblastoma

Clinical Cancer Research

Mary Jane Lim-Fat*

J Bryan Iorgulescu*

Rifaquat Rahman

Varun Bhave

Alona Muzikansky

...

2024/1/22

Aberrant DNA repair reveals a vulnerability in histone H3. 3-mutant brain tumors

Nucleic Acids Research

Giulia Giacomini

Sandra Piquet

Odile Chevallier

Juliette Dabin

Siau-Kun Bai

...

2024/3/21

Distribution of Copy Number Variants and Impact of Chromosome Arm Call Thresholds for Meningioma

Wenya Linda Bi

Ruchit Patel

Hia Ghosh

David Meredith

Scott Ryall

...

2024/3/5

Defining the landscape of cancer vulnerabilities that are engendered by germline genetic variation

Sean Misek

Aaron Fultineer

Jeremie Kalfon

Javad Noorbakhsh

Isabella Boyle

...

2023/6/1

Genomic sequence context differs between germline and somatic structural variants allowing for their differentiation in tumor samples without paired normals

bioRxiv

Wolu Chukwu

Siyun Lee

Alexander Crane

Shu Zhang

Ipsa Mittra

...

2023/10/12

DDDR-11. IDENTIFYING NEW VULNERABILITIES TO TARGET PEDIATRIC LOW-GRADE GLIOMA

Neuro-Oncology

Anna Borgenvik

Sean Misek

Jens Maile

Dana Novikov

Sher Bahadur

...

2023/11/1

Detecting significantly recurrent genomic connections from simple and complex rearrangements in the cancer genome

bioRxiv

Shu Zhang

Kiran H Kumar

Ofer Shapira

Xiaotong Yao

Jeremiah Wala

...

2023

Author Correction: Patterns of somatic structural variation in human cancer genomes

Nature

Yilong Li

Nicola D Roberts

Jeremiah A Wala

Ofer Shapira

Steven E Schumacher

...

2023/2/16

Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer (vol 52, pg 294, 2020)

Nature genetics

Kadir C Akdemir

Victoria T Le

Sahaana Chandran

Yilong Li

Roel G Verhaak

...

2020/3/2

Author Correction: Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer

nature genetics

Kadir C Akdemir

Victoria T Le

Sahaana Chandran

Yilong Li

Roel G Verhaak

...

2023/6

A sequence context-based germline filter for structural variant calling from tumor samples without paired normal

W Chukwu

S Lee

A Crane

S Zhang

I Mittra

...

2023/10/12

CTNI-17. APPLICATION OF THE GBM-X DATA PLATFORM TO ESTIMATE TREATMENT EFFECTS OF THE EXPERIMENTAL THERAPIES OF THE RANDOMIZED PHASE 2 INDIVIDUALIZED SCREENING TRIAL OF …

Neuro-Oncology

Rifaquat Rahman

Lorenzo Trippa

Geoffrey Fell

Eudocia Lee

Isabel Arrillaga-Romany

...

2023/11/1

Molecular Landscape and Contemporary Prognostic Signatures of Gliomas

medRxiv

Hia S Ghosh

Ruchit V Patel

Eleanor Woodward

Noah F Greenwald

Varun M Bhave

...

2023

Author Correction: The evolutionary history of 2,658 cancers

Nature

Moritz Gerstung

Clemency Jolly

Ignaty Leshchiner

Stefan C Dentro

Santiago Gonzalez

...

2023/2/16

Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition (vol 52, pg 306, 2020)

NATURE GENETICS

Bernardo Rodriguez-Martin

Eva G Alvarez

Adrian Baez-Ortega

Jorge Zamora

Fran Supek

...

2023/3/21

Author Correction: Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition

Nature

2023/2/16

Cancer aneuploidies are shaped primarily by effects on tumour fitness

Nature

Juliann Shih

Shahab Sarmashghi

Nadja Zhakula-Kostadinova

Shu Zhang

Yohanna Georgis

...

2023/7/27

PATH-12. CONTEMPORARY MOLECULAR LANDSCAPE, SURVIVAL, AND PROGNOSTIC FACTORS IN OVER 4,000 GLIOMAS

Neuro-Oncology

Hia Ghosh

Ruchit Patel

Eleanor Woodward

Noah Greenwald

Varun Bhave

...

2023/11/1

See List of Professors in Rameen Beroukhim University(Harvard University)

Rameen Beroukhim FAQs

What is Rameen Beroukhim's h-index at Harvard University?

The h-index of Rameen Beroukhim has been 127 since 2020 and 153 in total.

What are Rameen Beroukhim's top articles?

The articles with the titles of

The epigenetic evolution of glioma is determined by the IDH1 mutation status and treatment regimen

Author Correction: An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κB

Clinical and genomic predictors of adverse events in newly diagnosed glioblastoma

Aberrant DNA repair reveals a vulnerability in histone H3. 3-mutant brain tumors

Distribution of Copy Number Variants and Impact of Chromosome Arm Call Thresholds for Meningioma

Defining the landscape of cancer vulnerabilities that are engendered by germline genetic variation

Genomic sequence context differs between germline and somatic structural variants allowing for their differentiation in tumor samples without paired normals

DDDR-11. IDENTIFYING NEW VULNERABILITIES TO TARGET PEDIATRIC LOW-GRADE GLIOMA

...

are the top articles of Rameen Beroukhim at Harvard University.

What are Rameen Beroukhim's research interests?

The research interests of Rameen Beroukhim are: cancer genomics, brain cancers, endometrial cancer

What is Rameen Beroukhim's total number of citations?

Rameen Beroukhim has 165,106 citations in total.